Serotype-specific problems associated with pneumococcal conjugate vaccination (Q37071137)

18 August 2017

1 reference

title

Serotype-specific problems associated with pneumococcal conjugate vaccination (English)

1 reference

18 August 2017

1

William P Hanage

1 reference

18 August 2017

1 February 2008

1 reference

18 August 2017

8

1 reference

based on heuristic

inferred from page(s)

published in

Future Microbiology

1 reference

18 August 2017

3

1 reference

18 August 2017

23-30

1 reference

18 August 2017

1

1 reference

The burden of pneumococcal disease among adults in developed and developing countries: what is and is not known

18 August 2017

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.1.23

Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Northern California Kaiser Permanente Vaccine Study Center Group

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.1.23

Seven valent pneumococcal conjugate vaccine immunization in two Boston communities: changes in serotypes and antimicrobial susceptibility among Streptococcus pneumoniae isolates

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.1.23

Discovery of a new capsular serotype (6C) within serogroup 6 of Streptococcus pneumoniae

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.1.23

The contribution of specific pneumococcal serogroups to different disease manifestations: implications for conjugate vaccine formulation and use, part II.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.1.23

Which pneumococcal serogroups cause the most invasive disease: implications for conjugate vaccine formulation and use, part I.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.1.23

Indirect effect of conjugate vaccine on adult carriage of Streptococcus pneumoniae: an explanation of trends in invasive pneumococcal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.1.23

Post-PCV7 changes in colonizing pneumococcal serotypes in 16 Massachusetts communities, 2001 and 2004.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.1.23

Decline in Invasive Pneumococcal Disease after the Introduction of Protein–Polysaccharide Conjugate Vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.1.23

Decrease of invasive pneumococcal infections in children among 8 children's hospitals in the United States after the introduction of the 7-valent pneumococcal conjugate vaccine.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.1.23

Temporal trends of invasive disease due to Streptococcus pneumoniae among children in the intermountain west: emergence of nonvaccine serogroups.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.1.23

Incidence of pneumococcal disease due to non-pneumococcal conjugate vaccine (PCV7) serotypes in the United States during the era of widespread PCV7 vaccination, 1998-2004.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.1.23

Emergence of 19A as virulent and multidrug resistant Pneumococcus in Massachusetts following universal immunization of infants with pneumococcal conjugate vaccine.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.1.23

Postvaccine genetic structure of Streptococcus pneumoniae serotype 19A from children in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.1.23

Invasive pneumococcal disease caused by nonvaccine serotypes among alaska native children with high levels of 7-valent pneumococcal conjugate vaccine coverage

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.1.23

Recombinational exchanges at the capsular polysaccharide biosynthetic locus lead to frequent serotype changes among natural isolates of Streptococcus pneumoniae.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.1.23

Single-step capsular transformation and acquisition of penicillin resistance in Streptococcus pneumoniae

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.1.23

Pre- and postvaccination clonal compositions of invasive pneumococcal serotypes for isolates collected in the United States in 1999, 2001, and 2002

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.1.23

Emergence of a multiresistant serotype 19A pneumococcal strain not included in the 7-valent conjugate vaccine as an otopathogen in children

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.1.23

Invasiveness of serotypes and clones of Streptococcus pneumoniae among children in Finland

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.1.23

The epidemiology of invasive pneumococcal disease in Alaska, 1986-1990--ethnic differences and opportunities for prevention.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.1.23

Serotype distribution and antimicrobial resistance patterns of invasive isolates of Streptococcus pneumoniae: Alaska, 1991-1998.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.1.23

Impact of heptavalent pneumococcal conjugate vaccine on invasive disease, antimicrobial resistance and colonization in Alaska Natives: progress towards elimination of a health disparity

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.1.23

Invasive pneumococcal disease in Portugal prior to and after the introduction of pneumococcal heptavalent conjugate vaccine.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.1.23

Direct expenditures related to otitis media diagnoses: extrapolations from a pediatric medicaid cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.1.23

Ability of pneumococcal serotypes and clones to cause acute otitis media: implications for the prevention of otitis media by conjugate vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.1.23

Efficacy of a pneumococcal conjugate vaccine against acute otitis media

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.1.23

Childhood pneumonia mortality--a permanent global emergency

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.1.23

Bacterial pneumonia vaccines and childhood pneumonia: are we winning, refining, or redefining?

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.1.23

Pneumococcal vaccination in developing countries.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.1.23

The preventable burden of pneumococcal disease in the developing world

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.1.23

Efficacy of nine-valent pneumococcal conjugate vaccine against pneumonia and invasive pneumococcal disease in The Gambia: randomised, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.1.23

A trial of a 9-valent pneumococcal conjugate vaccine in children with and those without HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.1.23

Genetic analysis of the capsular biosynthetic locus from all 90 pneumococcal serotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.1.23

Serotype 14 variants of the Spanish penicillin-resistant serotype 9V clone of Streptococcus pneumoniae arose by large recombinational replacements of the cpsA-pbp1a region.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.1.23

A multilocus sequence typing scheme for Streptococcus pneumoniae: identification of clones associated with serious invasive disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.1.23

Multilocus sequence typing

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.1.23

Emergence of a novel penicillin-nonsusceptible, invasive serotype 35B clone of Streptococcus pneumoniae within the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.1.23

Diversity and Antibiotic Resistance among Nonvaccine Serotypes ofStreptococcus pneumoniaeCarriage Isolates in the Post–Heptavalent Conjugate Vaccine Era

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.1.23

Multilocus Sequence Typing ofStreptococcus pneumoniaeClones with Unusual Drug Resistance Patterns: Genetic Backgrounds and Relatedness to Other Epidemic Clones

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.1.23

Pitfalls in Case-Control Studies of Vaccine Effectiveness

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.1.23

21 January 2018

Identifiers

DOI

10.2217/17460913.3.1.23

1 reference

18 August 2017

1 reference

PubMed ID

18230031